loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 202539 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 PARICALCITOL (3)

filter

01 BIONPHARMA (3)

filter

01 CAPSULE;ORAL (3)

filter

01 1MCG (1)

02 2MCG (1)

03 4MCG (1)

filter

01 USA (3)

URL Supplier Web Content
CAPSULE;ORAL
2MCG
PARICALCITOL
USA
202539
2014-03-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE;ORAL
4MCG
PARICALCITOL
USA
202539
2014-03-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE;ORAL
1MCG
PARICALCITOL
USA
202539
2014-03-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 202539

Looking for CTD TGA MCC DOSSIER APPLICATION 202539 3

19

Bionpharma, based in U.S.A, is a pharmaceutical company.

One of their notable products is PARICALCITOL, with a corresponding application number 202539 and regulatory information .

proudly manufactured in the

approval since 2014-03-27

Bionpharma's PARICALCITOL CAPSULE;ORAL, medication with 2MCG of PARICALCITOL.

18

Bionpharma, based in U.S.A, is a pharmaceutical company.

One of their notable products is PARICALCITOL, with a corresponding application number 202539 and regulatory information .

proudly manufactured in the

approval since 2014-03-27

Bionpharma's PARICALCITOL CAPSULE;ORAL, medication with 4MCG of PARICALCITOL.

17

Bionpharma, based in U.S.A, is a pharmaceutical company.

One of their notable products is PARICALCITOL, with a corresponding application number 202539 and regulatory information .

proudly manufactured in the

approval since 2014-03-27

Bionpharma's PARICALCITOL CAPSULE;ORAL, medication with 1MCG of PARICALCITOL.

Post Enquiry
POST ENQUIRY